• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性心脏间隔缺损患儿中TBX20和CITED2突变的筛查与评估:与心肌肌钙蛋白T和半胱天冬酶-3的相关性

Screening and evaluation of TBX20 and CITED2 mutations in children with congenital cardiac septal defects: Correlation with cardiac troponin T and caspase-3.

作者信息

Taha Mohamed, Awny Nourhan, Ismail Somaia, Ashaat Engy A, Senousy Mahmoud A

机构信息

Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt.

Medical Molecular Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Giza, Egypt.

出版信息

Gene. 2023 Oct 5;882:147660. doi: 10.1016/j.gene.2023.147660. Epub 2023 Jul 20.

DOI:10.1016/j.gene.2023.147660
PMID:37481008
Abstract

Congenital cardiac septal defect (CCSD) is the main type of congenital heart disease and owns a very high mortality rate among newborns. CCSD is controlled by specific transcription factors, including T-box transcription factor 20 (TBX20) and Cbp/P300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 (CITED2) which are key molecular actors in heart development. Here, we screened for mutations in TBX20 and CITED2 genes in Egyptian children with CCSD and assessed their association with CCSD susceptibility and with cardiac troponin T (cTnT) and the apoptotic marker caspase-3 as biochemical markers for CCSD. Thirty unrelated newborns and children affected with CCSD and 30 matched healthy controls with no personal history of cardiac diseases were recruited. Selection criteria were children (<18 years) with any age diagnosed with CCSD using ECHO. Mutational analysis and genotyping were done using PCR-Sanger DNA sequencing technique. Serum cTnT and caspase-3 were analyzed using ELISA. Sequencing analysis identified 2 TBX20 variants (c.766T>C and c.39T>C) in the CCSD and control groups and 2 CITED2 variants (c.12T>C and c.9C>T) in one CCSD patient, while were absent in controls. In silico analysis identified TBX20 c.766T>C (rs3999941) as a missense (F256L) pathogenic variant and the other three variants as synonymous and benign. Compared with controls, TBX20 c.766T>C TC genotype and minor C allele were candidate high-risk factors for CCSD. Besides, serum cTnT and caspase-3 were dramatically elevated in CCSD children compared to controls. TBX20 c.766T>C TC genotype was associated with high cTnT in CCSD children. Conclusively, we advocate TBX20 c.766T>C variant as a potential genetic marker for CCSD which might associate with high cTnT levels. CITED2 genetic variants might have rare incidence among Egyptian CCSD children. Serum cTnT and caspase-3 are useful markers for ascertaining CCSD in children. These data could be exploited in prenatal genetic counseling, pre-implantation genotyping, and therapy of CCSD.

摘要

先天性心脏间隔缺损(CCSD)是先天性心脏病的主要类型,在新生儿中死亡率很高。CCSD由特定转录因子控制,包括T盒转录因子20(TBX20)和富含谷氨酸/天冬氨酸的羧基末端结构域2的Cbp/P300相互作用反式激活因子(CITED2),它们是心脏发育中的关键分子。在此,我们筛查了埃及CCSD患儿TBX20和CITED2基因的突变,并评估了它们与CCSD易感性以及与心肌肌钙蛋白T(cTnT)和凋亡标志物半胱天冬酶-3的关联,将其作为CCSD的生化标志物。招募了30名患有CCSD的无关新生儿和儿童以及30名匹配的无心脏病个人史的健康对照。选择标准为使用超声心动图诊断为CCSD的任何年龄的儿童(<18岁)。使用PCR-桑格DNA测序技术进行突变分析和基因分型。使用酶联免疫吸附测定法分析血清cTnT和半胱天冬酶-3。测序分析在CCSD组和对照组中鉴定出2种TBX20变体(c.766T>C和c.39T>C),在1例CCSD患者中鉴定出2种CITED2变体(c.12T>C和c.9C>T),而在对照组中未发现。生物信息学分析确定TBX20 c.766T>C(rs3999941)为错义(F²⁵⁶L)致病变体,其他三种变体为同义且良性。与对照组相比,TBX20 c.766T>C的TC基因型和次要C等位基因是CCSD的候选高危因素。此外,与对照组相比,CCSD患儿的血清cTnT和半胱天冬酶-3显著升高。TBX20 c.766T>C的TC基因型与CCSD患儿的高cTnT相关。总之,我们主张将TBX20 c.766T>C变体作为CCSD的潜在遗传标志物,它可能与高cTnT水平相关。CITED2基因变体在埃及CCSD患儿中的发生率可能很低。血清cTnT和半胱天冬酶-3是确定儿童CCSD的有用标志物。这些数据可用于产前遗传咨询、植入前基因分型和CCSD的治疗。

相似文献

1
Screening and evaluation of TBX20 and CITED2 mutations in children with congenital cardiac septal defects: Correlation with cardiac troponin T and caspase-3.先天性心脏间隔缺损患儿中TBX20和CITED2突变的筛查与评估:与心肌肌钙蛋白T和半胱天冬酶-3的相关性
Gene. 2023 Oct 5;882:147660. doi: 10.1016/j.gene.2023.147660. Epub 2023 Jul 20.
2
Mutations in cardiac T-box factor gene TBX20 are associated with diverse cardiac pathologies, including defects of septation and valvulogenesis and cardiomyopathy.心脏T盒因子基因TBX20的突变与多种心脏疾病相关,包括间隔形成和瓣膜发生缺陷以及心肌病。
Am J Hum Genet. 2007 Aug;81(2):280-91. doi: 10.1086/519530. Epub 2007 Jun 15.
3
Association of TBX20 gene polymorphism with congenital heart disease in Han Chinese neonates.汉族新生儿TBX20基因多态性与先天性心脏病的关联
Pediatr Cardiol. 2015 Apr;36(4):737-42. doi: 10.1007/s00246-014-1073-5. Epub 2014 Dec 9.
4
Missense mutations in the CITED2 gene may contribute to congenital heart disease.CITED2 基因中的错义突变可能导致先天性心脏病。
BMC Cardiovasc Disord. 2024 Sep 27;24(1):516. doi: 10.1186/s12872-024-04035-2.
5
T-box transcription factor TBX20 mutations in Chinese patients with congenital heart disease.中国先天性心脏病患者中T盒转录因子TBX20的突变
Eur J Med Genet. 2008 Nov-Dec;51(6):580-7. doi: 10.1016/j.ejmg.2008.09.001. Epub 2008 Sep 12.
6
Novel Point Mutations of CITED2 Gene Are Associated with Non-familial Congenital Heart Disease (CHD) in Sporadic Pediatric Patients.CITED2 基因的新突变与散发性儿科先心病(CHD)相关。
Appl Biochem Biotechnol. 2020 Mar;190(3):896-906. doi: 10.1007/s12010-019-03125-8. Epub 2019 Sep 13.
7
A gain-of-function mutation in CITED2 is associated with congenital heart disease.CITED2 中的功能获得性突变与先天性心脏病有关。
Mutat Res. 2021 Jan-Jun;822:111741. doi: 10.1016/j.mrfmmm.2021.111741. Epub 2021 Mar 1.
8
A novel variant in TBX20 (p.D176N) identified by whole-exome sequencing in combination with a congenital heart disease related gene filter is associated with familial atrial septal defect.通过全外显子组测序结合先天性心脏病相关基因筛选鉴定出的TBX20基因的一种新型变异(p.D176N)与家族性房间隔缺损相关。
J Zhejiang Univ Sci B. 2014 Sep;15(9):830-7. doi: 10.1631/jzus.B1400062.
9
Genetic analysis of the CITED2 gene promoter in isolated and sporadic congenital ventricular septal defects.孤立性和散发性先天性室间隔缺损中 CITED2 基因启动子的遗传分析。
J Cell Mol Med. 2021 Feb;25(4):2254-2261. doi: 10.1111/jcmm.16218. Epub 2021 Jan 13.
10
Identification and functional analysis of CITED2 mutations in patients with congenital heart defects.先天性心脏病患者中CITED2基因突变的鉴定与功能分析。
Hum Mutat. 2005 Dec;26(6):575-82. doi: 10.1002/humu.20262.

引用本文的文献

1
Identification and Functional Characterization of a Novel Mutation Predisposing to Coffin-Siris Syndromic Congenital Heart Disease.一种导致科芬-西里斯综合征相关先天性心脏病的新型突变的鉴定与功能表征。
Children (Basel). 2025 May 7;12(5):608. doi: 10.3390/children12050608.
2
Chromosomal Location and Identification of as a New Gene Responsible for Familial Bicuspid Aortic Valve.作为家族性二叶式主动脉瓣致病新基因的染色体定位与鉴定
Diagnostics (Basel). 2025 Mar 1;15(5):600. doi: 10.3390/diagnostics15050600.
3
Missense mutations in the CITED2 gene may contribute to congenital heart disease.
CITED2 基因中的错义突变可能导致先天性心脏病。
BMC Cardiovasc Disord. 2024 Sep 27;24(1):516. doi: 10.1186/s12872-024-04035-2.